Document Detail


Tumor markers and TNM classification
MedLine Citation:
PMID:  9797825     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Some tumor markers were demonstrated as being significant prognostic factors of cancer patients and are proposed to be included in the TNM classification. However, only serum ALP fulfils the criteria in patients with osteosarcoma. The author proposes the concept of "cancer related molecular markers," including circulating tumor markers and genomic changes. Their messages and products should be evaluated if it is a major independent prognostic factor of a cancer and its assay is easy and reproducible.
Authors:
H Ohkura
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Gan to kagaku ryoho. Cancer & chemotherapy     Volume:  25     ISSN:  0385-0684     ISO Abbreviation:  Gan To Kagaku Ryoho     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1998-11-04     Completed Date:  1998-11-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7810034     Medline TA:  Gan To Kagaku Ryoho     Country:  JAPAN    
Other Details:
Languages:  jpn     Pagination:  1981-4     Citation Subset:  IM    
Affiliation:
Medical Oncology Division, Ibaraki Kenritsu Chuo Hospital & Cancer Center, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Humans
Neoplasms / blood*,  genetics
Prognosis
Risk
Stomach Neoplasms / blood,  mortality
Tumor Markers, Biological / blood,  classification*
Tumor Suppressor Protein p53 / genetics
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological; 0/Tumor Suppressor Protein p53

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of ...
Next Document:  The course of anaemia after the treatment of acute, falciparum malaria.